Cardiff Oncology
CRDF
58 hedge funds and large institutions have $47.3M invested in Cardiff Oncology in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 9 reducing their positions, and 13 closing their positions.
256% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 9
12% less funds holding
Funds holding: 66 → 58 (-8)
13% less call options, than puts
Call options by funds: $686K | Put options by funds: $793K
16% less capital invested
Capital invested by funds: $56.3M → $47.3M (-$9.06M)
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIG
American International Group
New York
|
+$444K |
| 2 |
State Street
Boston,
Massachusetts
|
+$324K |
| 3 |
Goldman Sachs
New York
|
+$261K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$236K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$223K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
-$2.03M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$548K |
| 3 |
CC
Casdin Capital
New York
|
-$378K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$355K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$169K |
CRDF Hedge Fund Activity: Q1 2016 in Review
58 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q1 2016, worth a combined $47.3M — down 16% from $56.3M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of CRDF and 6 opened new positions — a net loss of 7 holders — while 9 trimmed existing stakes and 32 added.
The largest buyer was American International Group, adding an estimated $444K. The largest seller was First Eagle Investment Management, exiting entirely with an estimated $2.03M sold.
- 58 institutional investors held Cardiff Oncology (CRDF) as of Q1 2016, down from 66 in Q4 2015.
- Funds reported $47.3M of Cardiff Oncology stock for Q1 2016, down 16% quarter-over-quarter.
- 6 funds opened new Cardiff Oncology positions in Q1 2016 and 13 closed out, a net change of -7 holders.
- The largest Cardiff Oncology buyer in Q1 2016 was American International Group, an estimated $444K added.
- The largest Cardiff Oncology seller in Q1 2016 was First Eagle Investment Management, an estimated $2.03M sold.
Based on aggregated 13F filings for Q1 2016.